Cargando…
Melioidosis Vaccines: A Systematic Review and Appraisal of the Potential to Exploit Biodefense Vaccines for Public Health Purposes
BACKGROUND: Burkholderia pseudomallei is a Category B select agent and the cause of melioidosis. Research funding for vaccine development has largely considered protection within the biothreat context, but the resulting vaccines could be applicable to populations who are at risk of naturally acquire...
Autores principales: | Peacock, Sharon J., Limmathurotsakul, Direk, Lubell, Yoel, Koh, Gavin C. K. W., White, Lisa J., Day, Nicholas P. J., Titball, Richard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269417/ https://www.ncbi.nlm.nih.gov/pubmed/22303489 http://dx.doi.org/10.1371/journal.pntd.0001488 |
Ejemplares similares
-
Correction: Melioidosis Vaccines: A Systematic Review and Appraisal of the Potential to Exploit Biodefense Vaccines for Public Health Purposes
por: Peacock, Sharon J., et al.
Publicado: (2013) -
Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand
por: Hantrakun, Viriya, et al.
Publicado: (2015) -
The global impact and cost-effectiveness of a melioidosis vaccine
por: Luangasanatip, Nantasit, et al.
Publicado: (2019) -
New Insights from the 7th World Melioidosis Congress 2013
por: Schweizer, Herbert P., et al.
Publicado: (2014) -
Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
por: Limmathurotsakul, Direk, et al.
Publicado: (2015)